241 related articles for article (PubMed ID: 9155516)
1. Is screening for prostate cancer the current gold standard?--"yes".
Lange PH
Eur J Cancer; 1997 Mar; 33(3):354-6. PubMed ID: 9155516
[No Abstract] [Full Text] [Related]
2. Is screening for prostate cancer the current gold standard?--"no".
Kramer BS; Gohagan JK; Prorok PC
Eur J Cancer; 1997 Mar; 33(3):348-53. PubMed ID: 9155515
[No Abstract] [Full Text] [Related]
3. Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker.
Hamilton RJ; Platz EA; Freedland SJ
J Natl Cancer Inst; 2009 Apr; 101(8):611-2. PubMed ID: 19351913
[No Abstract] [Full Text] [Related]
4. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
5. [Mass screening for prostate cancer will have to wait. The scientific basis insufficient, more efficient markers necessary].
Damber JE
Lakartidningen; 2003 Sep; 100(38):2916-8, 2921. PubMed ID: 14558209
[No Abstract] [Full Text] [Related]
6. Application of prostate-specific antigen in prostate cancer.
Liang SL
MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
[No Abstract] [Full Text] [Related]
7. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
Belpomme D; Irigaray P
J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186
[No Abstract] [Full Text] [Related]
8. [Mass screening for prostate cancer is the best approach to early diagnosis and treatment of prostate cancer].
Zhao XJ; Kong XB; Wang WH
Zhonghua Nan Ke Xue; 2003 Nov; 9(8):563-5, 568. PubMed ID: 14689882
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer: enthusiasm for screening.
Kaye KW
Med J Aust; 1995 May; 162(10):540-1. PubMed ID: 7539884
[No Abstract] [Full Text] [Related]
10. Best screening tests for prostate cancer.
Moul JW
West J Med; 1998 Aug; 169(2):109-10. PubMed ID: 9735692
[No Abstract] [Full Text] [Related]
11. Is an improved PSA screening test in sight?
Savage L
J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
[No Abstract] [Full Text] [Related]
12. PSA screening: the bottom line.
Elhilali MM
CMAJ; 2000 Mar; 162(6):791-2. PubMed ID: 10750466
[No Abstract] [Full Text] [Related]
13. Prostate-specific antigen: a misused and maligned prostate cancer biomarker.
Thompson IM; Tangen CM; Kristal AR
J Natl Cancer Inst; 2008 Nov; 100(21):1487-8. PubMed ID: 18957671
[No Abstract] [Full Text] [Related]
14. [Mass screening for prostate cancer in Nagano].
Ishizuka O; Satoh T; Kobayashi S; Nishizawa O
Hinyokika Kiyo; 2001 Nov; 47(11):769-72. PubMed ID: 11771167
[TBL] [Abstract][Full Text] [Related]
15. Early detection of prostate cancer: is PSA a reliable option?
Okihara K; Babaian RJ
Tex Med; 2001 Feb; 97(2):59-62. PubMed ID: 11233061
[TBL] [Abstract][Full Text] [Related]
16. Mass screening for prostate cancer. The Swedish Council on Technology Assessment in Health Care.
Int J Cancer Suppl; 1996; 9():1-72. PubMed ID: 8982323
[No Abstract] [Full Text] [Related]
17. PSA and prostate cancer screening: the challenge of the new millennium.
Bjartell A
Eur Urol; 2007 Nov; 52(5):1284-6. PubMed ID: 17720305
[No Abstract] [Full Text] [Related]
18. [The prostate specific antigen: what can we learn from the American experience?].
Zhao XJ
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
[No Abstract] [Full Text] [Related]
19. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
Ito K
Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
[No Abstract] [Full Text] [Related]
20. [Based on current knowledge the introduction of the PSA screening for prostatic cancer is unethical].
Krantz I; Sachs L; Ahlberg BM; Nordin P; Nilstun T
Lakartidningen; 2005 Sep 5-11; 102(36):2498-500. PubMed ID: 16196436
[No Abstract] [Full Text] [Related]
[Next] [New Search]